Dynamic, personalized treatment approach may improve outcomes in gastroesophageal cancers
A University of Chicago study found that when treatments are customized for gastric cancer patients based on the genetic characteristics of their... Read More
Single-cell analysis of metastatic gastric cancer finds diverse tumor cell populations associated with patient outcomes
MD Anderson researchers identified two subtypes of peritoneal carcinomatosis, a form of gastric cancer, and developed gene expression signatures that can be... Read More
Hispanic/Latino gastric adenocarcinoma patients have distinct molecular profiles including a high rate of germline CDH1 mutations
Gene sequencing revealed a high rate of mutations that raise the risk of gastric cancer among people of hispanic origins, according to... Read More
Curbing Cancer’s Addiction to Treat It
In a new study, Australian researchers describe how they stopped gastric cancer growth in lab models by neutralizing a gene receptor called... Read More
ESMO Clinical Practice Guidelines for Surveillance of Hereditary Gastrointestinal Cancers
The European Society for Clinical Oncology (ESMO) issued new recommendations for screening patients who may face a high risk of gastrointestinal cancer.... Read More
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Researchers at MD Anderson used DNA and RNA sequencing to identify gene mutations linked with aggressive peritoneal metastases in gastric cancer.
Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
“Gastric cancer with FGFR2b overexpression or FGFR2 gene amplification is associated with a poor prognosis for patients with advanced disease,” said Helen... Read More
